Literature DB >> 7584990

Decreased expression of AMPA receptor messenger RNA and protein in AIDS: a model for HIV-associated neurotoxicity.

I P Everall, L Hudson, S al-Sarraj, M Honavar, P Lantos, R Kerwin.   

Abstract

HIV infection can cause extensive neuronal loss and clinically a severe dementia. The cause of the neurotoxicity remains unclear as neurons are not infected, but disturbance of glutamate-linked calcium entry has been implicated. In this study, we have shown a decrease in HIV-infected brain of the expression of mRNA and protein of the GluR-A flop subtype of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) glutamate receptor in cerebellar Purkinje cells. Although Purkinje cells are relatively resistant to loss, the observed disturbance of AMPA receptors may contribute to the neurotoxic process in other vulnerable brain regions and clinically to the development of dementia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7584990     DOI: 10.1038/nm1195-1174

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  14 in total

1.  LP-BM5 virus-infected mice produce activating autoantibodies to the AMPA receptor.

Authors:  E Koustova; Y Sei; L Fossom; M L Wei; P N Usherwood; N B Keele; M A Rogawski; A S Basile
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

Review 2.  Neurotoxicity of human immunodeficiency virus-1: viral proteins and axonal transport.

Authors:  Italo Mocchetti; Alessia Bachis; Valeriya Avdoshina
Journal:  Neurotox Res       Date:  2011-09-27       Impact factor: 3.911

3.  High transgene expression by lentiviral vectors causes maldevelopment of Purkinje cells in vivo.

Authors:  Yusuke Sawada; Go Kajiwara; Akira Iizuka; Kiyohiko Takayama; Anton N Shuvaev; Chiho Koyama; Hirokazu Hirai
Journal:  Cerebellum       Date:  2010-09       Impact factor: 3.847

4.  Pontocerebellar contribution to postural instability and psychomotor slowing in HIV infection without dementia.

Authors:  Edith V Sullivan; Margaret J Rosenbloom; Torsten Rohlfing; Carol A Kemper; Stanley Deresinski; Adolf Pfefferbaum
Journal:  Brain Imaging Behav       Date:  2011-03       Impact factor: 3.978

5.  Brain-derived neurotrophic factor expression in the substantia nigra does not change after lesions of dopaminergic neurons.

Authors:  Italo Mocchetti; Alessia Bachis; Rachel L Nosheny; Gianluigi Tanda
Journal:  Neurotox Res       Date:  2007-09       Impact factor: 3.911

Review 6.  Pathogenic mechanisms of neuronal damage in the AIDS dementia complex.

Authors:  S Swingler
Journal:  Mol Pathol       Date:  1997-04

7.  Human immunodeficiency virus type 1 alters brain-derived neurotrophic factor processing in neurons.

Authors:  Alessia Bachis; Valeriya Avdoshina; Luigi Zecca; Maia Parsadanian; Italo Mocchetti
Journal:  J Neurosci       Date:  2012-07-11       Impact factor: 6.167

Review 8.  When human immunodeficiency virus meets chemokines and microglia: neuroprotection or neurodegeneration?

Authors:  Italo Mocchetti; Lee A Campbell; G Jean Harry; Valeriya Avdoshina
Journal:  J Neuroimmune Pharmacol       Date:  2012-04-15       Impact factor: 4.147

Review 9.  Brain-derived neurotrophic factor as a prototype neuroprotective factor against HIV-1-associated neuronal degeneration.

Authors:  R L Nosheny; I Mocchetti; A Bachis
Journal:  Neurotox Res       Date:  2005-10       Impact factor: 3.911

10.  CXCR4 and CXCL12 expression is increased in the nigro-striatal system of Parkinson's disease.

Authors:  Mika Shimoji; Fernando Pagan; Edward B Healton; Italo Mocchetti
Journal:  Neurotox Res       Date:  2009-06-24       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.